| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |